Research on head and neck cancers promising

IN recognition of June as Cancer Immunotherapy Month, the Head and Neck cancer team in Cancer Research Malaysia (formerly known as Cancer Research Initiatives Foundation), would like to share the work we are doing in this sphere.

In 2016, Dr Julie Vose, president of the American Society of Clinical Oncology (Asco), declared, “No recent advance has been more transformative than the rise of immunotherapy, particularly over this past year, making immunotherapy the American Society of Clinical Oncology’s (Asco’s) Advance of the Year.”